LISATA THERAPEUTICS, INC. (LSTA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 400K 800K 1.2M Q3 '24: 0 Q4 '24: 1M Q1 '25: 1M Q2 '25: 1.1M Q3 '25: 1.1M Q4 '25: 170K Q1 '26: 170K Q2 '26: 100K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 7M 14M 21M Q1 '11: 20.5M Q2 '11: 14.4M Q3 '11: 9.5M Q4 '12: 2.4M Q1 '13: 1.7M Q2 '13: 1.2M Q3 '13: 1.2M Q4 '13: 1.7M Q1 '11 Q2 '11 Q3 '11 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13

Operating Income TTM

-24M -16M -8M 0 8M 16M 24M Q3 '24: -23.5M Q4 '24: -22.4M Q1 '25: -21.7M Q2 '25: -21M Q3 '25: -20.1M Q4 '25: -18.2M Q1 '26: -17.3M Q2 '26: -16.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q3 '24: -20.7M Q4 '24: -20M Q1 '25: -19.3M Q2 '25: -18.9M Q3 '25: -18.2M Q4 '25: -16.6M Q1 '26: -16.4M Q2 '26: -14.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q2 '15: 17.3M Q3 '15: 18.1M Q4 '15: 20.2M Q1 '16: 23M Q2 '16: 24.3M Q3 '16: 28.1M Q4 '16: 31.1M Q1 '17: 33M Q2 '15 Q3 '15 Q4 '15 Q1 '16 Q2 '16 Q3 '16 Q4 '16 Q1 '17

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '24: -18.9M Q4 '24: -19.4M Q1 '25: -17.7M Q2 '25: -16.4M Q3 '25: -17.2M Q4 '25: -15.9M Q1 '26: -13.6M Q2 '26: -12.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '24: -18.9M Q4 '24: -19.4M Q1 '25: -17.8M Q2 '25: -16.4M Q3 '25: -17.3M Q4 '25: -16M Q1 '26: -13.6M Q2 '26: -12.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5M 7M 10.5M Q1 '24: 8.3M Q2 '24: 8.3M Q3 '24: 8.3M Q1 '25: 8.6M Q2 '25: 8.6M Q3 '25: 8.7M Q1 '26: 9M Q2 '26: 9.1M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q3 '24: -2.51 Q4 '24: -2.40 Q1 '25: -2.30 Q2 '25: -2.23 Q3 '25: -2.13 Q4 '25: -1.91 Q1 '26: -1.86 Q2 '26: -1.64 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.